Distillate US Fundamental Stability & Value ETF

DSTL

Market cap $1.82B

DSTL offers a diversified, defensive large-cap value portfolio, with modest top holding weights and sector allocations favoring quality and stability. Recent performance shows DSTL's resilience, with lower volatility and less drawdown compared to the S&P 500, despite some recent underperformance. Macroeconomic risks—slowing growth, labor market weakness, and higher inflation—support a defensive, value-oriented approach in the near term.

Distillate US Fundamental Stability & Value ETF (DSTL) focuses on strong balance sheets, stable cash flows, and attractive valuations, offering downside protection but mixed performance in risk-on environments. DSTL is well-positioned for defensive exposure with significant allocations to healthcare and industrials, while underweight in technology and financial services, reflecting a value-oriented strategy. The fund trades at a substantial valuation discount to the Russell 1000, driven by lower exposure to high-multiple sectors like technology.

Distillate U.S. Fundamental Stability & Value ETF holds 100 stocks with a focus on free cash flow and low debt. DSTL features attractive valuation metrics, high dividend growth rate and good performance compared to competitors. DSTL is a compelling equity ETF for investors willing to avoid concentration in the tech industry and mega-caps.

The Distillate U.S. Fundamental Stability & Value ETF blends primary and peripheral factors to optimize value-investing. The fund's methodology focuses on high-quality value stocks with high free cash flow yields, low debt, and stable cash flows. DSTL has historically outperformed the SPDR S&P 500 ETF Trust, illustrating its ability to generate excess returns.

DSTL ETF filters out lower-quality companies based on financial measures and primarily uses free cash flow to gauge valuations. Portfolio consists of stable businesses in healthcare and industrial sectors, avoiding mega caps. DSTL has performed on par with benchmarks over the past 5 years, offering diversification and reasonable valuations without lower-quality companies.

Distillate U.S. Fundamental Stability & Value ETF is a fund focused on cash flow generation, screening for stable, profitable companies with low debt ratios and attractive valuations. The DSTL fund holds about 100 large-cap US stocks, with a diverse sector mix and top positions in Health Care, offering a different dynamic from passive benchmarks. DSTL has outperformed similar funds in the past two years, but the active approach may not continue to outperform in all market conditions.

DSTL is an actively-managed U.S. value ETF. It focuses on large-cap blue-chips, think Johnson & Johnson or AbbVie. The fund is cheaper than the S&P 500, and has outperformed since inception too, unlike most of its value peers.

The Distillate U.S. Fundamental Stability & Value ETF aims to provide investors with exposure to undervalued stocks with stable cash flows. The ETF uses a proprietary algorithm to select stocks based on fundamental stability and value factors. Though it has outperformed the market since its inception in 2018, interested investors should consider the long-term implications.

DSTL, an actively managed vehicle focused on top-quality U.S. stocks with copious free cash flows, has reconstituted its portfolio since my December note. DSTL has become more attractive from a valuation standpoint, with quality definitely remaining robust. Unfortunately, there is something to dislike about growth. I am of the opinion that there are ample reasons for a Buy rating.

DSTL is an actively managed FCF-focused ETF, prioritizing fundamental stability and value. DSTL has an exceedingly convincing performance track record, as it beat IVV in 33 out of 61 of its full trading months since its launch in October 2018. There is a solid factor mix under the hood, with a plethora of adequately valued, cash-rich names with low leverage and impressive capital efficiency.